Predictive Value of CD44v6 and EGFR Expression in Neoadjuvant Chemotherapy Sensitivity of Stage Ⅱ-Ⅲ Cervical Cancer

Predictive Value of CD44v6 and EGFR Expression in Neoadjuvant Chemotherapy Sensitivity of Stage Ⅱ-Ⅲ Cervical Cancer

Objective To explore the predictive value of the expression of CD44v6 and EGFR on the efficacy of neoadjuvant chemotherapy (NACT) in stageⅡ-Ⅲ cervical cancer. Methods A total of 53 patients with stageⅡ-Ⅲ cervical cancer diagnosed by pathology were selected. All patients received two cycles of paclit...

Full description

Bibliographic Details
Main Authors: MAO Wanli, RAN Li, LI Jiehui, LI Fenghu, CHANG Jianying, MU Junyu, MEI Fan, HU Lili, DU Yanjun, TIAN Xue, QIN Yao, YIN Shuishui
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2022-09-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
cervical cancer
neoadjuvant chemotherapy
cd44v6
egfr
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0038

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2022.22.0038

Similar Items